查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1755899

2032 年晶片实验室市场预测：按产品、材料、技术、应用、最终用户和地区进行的全球分析

Lab-on-a-chip Market Forecasts to 2032 - Global Analysis By Product (Reagents & Consumables, Instruments and Software & Services), Material, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球晶片实验室市场预计在 2025 年达到 73 亿美元，到 2032 年将达到 155 亿美元，预测期内的复合年增长率为 11.3%。

晶片实验室是一种紧凑型分析设备，将多个实验室流程整合到单一微流体平台上。这些系统效率高，能够以极少的样本需求快速进行生化和分子生物学分析。透过简化诊断程序、药物检测和环境监测，它们在提供准确结果的同时，优化了资源消耗。其自动化功能和即时检测能力增强了生物医学研究和即时诊断应用。

对照护现场（POC）的需求不断增长

微型分析仪提供快速且准确的检测，无需进行大量检测，并有助于立即做出医疗决策。随着慢性病的增多，临床医生需要高效的诊断解决方案，以确保及时介入。晶片实验室系统提供了一种经济高效且易于使用的传统诊断方法替代方案，使其成为远距和分散医疗环境中不可或缺的医疗方案。

复杂的设计与製造挑战

先进的微流体系统需要精密的工程设计和专用材料，增加了开发成本。在单一晶片上整合多种测试功能需要极高的製造精度，这给大规模生产带来了障碍。此外，确保与现有诊断工作流程的兼容性在技术上也极具挑战性，阻碍了市场的成长。

新的器官晶片和人体晶片模型

新的创新平台能够重现生理状态，使研究人员能够更有效地研究疾病机制和治疗反应。采用微工程组织的晶片实验室设备能够预测药物疗效，并减少对动物试验的依赖。製药公司和研究机构正在投资先进的晶片模型，以加速临床试验和个人化医疗的发展。

与传统测试设备的竞争

与传统检测设备的竞争对晶片实验室在某些领域的应用构成了挑战。集中式分析仪和自动化实验室系统等成熟的诊断工具凭藉其高通量和标准化的方案，仍然在临床领域占据主导地位。医疗保健提供者可能出于对准确性、监管核准以及与现有基础设施整合方面的担忧，不愿转向基于晶片的平台。

COVID-19的影响：

疫情凸显了快速分散诊断的重要性，并引发了人们对晶片实验室技术的兴趣。对能够高效检测感染疾病并减少对集中式实验室依赖的可携式检测解决方案的需求激增。研发工作正在加速推进，以开发高灵敏度、快速的COVID-19诊断晶片，进而提升疾病监测能力。然而，供应链中断影响了生产进度，暂时减缓了市场扩张。

试剂和耗材部分预计将在预测期内成为最大的部分

预计在预测期内，试剂和耗材领域将占据最大的市场占有率，这得益于晶片实验室运作所必需的化学成分的稳定需求。这些材料有助于微流体系统内的样品製备、生化反应和分析过程。晶片实验室设备在诊断实验室、药物研究和环境监测领域的应用日益广泛，推动了试剂消耗的稳定成长。

预计微流体技术领域在预测期内将实现最高的复合年增长率。

预计在预测期内，微流体技术领域将实现最高成长率，这得益于基于晶片的分析系统的进步。微流体创新优化了流体处理、反应动力学和多重检测，从而提高了诊断的准确性和效率。奈米技术与人工智慧主导的自动化相结合将进一步增强微流体的性能，扩大其在生物医学应用中的作用。

占比最大的地区：

在预测期内，北美预计将占据最大的市场占有率，这得益于其强大的医疗基础设施、大量的科研投入以及先进诊断技术的广泛应用。该地区对精准医疗和分散式检查的高度重视，使得晶片实验室解决方案在临床和製药领域备受瞩目。监管机构的支持以及微流体技术的持续创新，进一步巩固了北美在全球市场的领先地位。

复合年增长率最高的地区：

在预测期内，由于医疗保健可近性的提高、技术进步以及生物医学研究倡议的不断扩展，预计亚太地区将呈现最高的复合年增长率。政府对诊断创新的资助以及个人化医疗的兴起正在刺激对晶片实验室技术的需求。生物技术产业的发展，尤其是在中国、日本和印度，正在推动市场成长，使亚太地区成为下一代诊断发展的活跃中心。

免费客製化服务：

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的SWOT分析（最多3家公司）
  • 地理细分
    • 根据客户兴趣对主要国家市场进行估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

第五章 全球晶片实验室市场（按产品）

  • 试剂和耗材
    • 微流体晶片/墨盒
    • 珠子和颗粒
    • 检测试剂
    • 缓衝液和溶液
  • 装置
    • 样品製备单元
    • 整合 LOC 系统
    • 配件
  • 软体和服务
    • 数据分析软体
    • 自动化和控制软体
    • 云端基础的解决方案
    • 客製化晶片设计和製造服务
    • 维护和支援服务
    • 培训和咨询服务

第六章 全球晶片实验室市场（依材料）

  • 聚合物
  • 玻璃
  • 硅
  • 纸
  • 其他材料

第七章 全球晶片实验室市场（按技术）

  • 微流体
  • 光学技术
  • 电化学技术
  • 微阵列
  • 组织生物晶片/器官晶片
  • 其他技术

第八章 全球晶片实验室市场（按应用）

  • 临床诊断
  • 药物研发
  • 基因组学和蛋白​​质组学
  • 环境监测
  • 食品安全和品管
  • 其他用途

第九章 全球晶片实验室市场（按最终用户）

  • 医院和诊断中心
  • 生物技术和製药公司
  • 学术研究所
  • 法医学研究所
  • 其他最终用户

第 10 章 全球晶片实验室市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Becton, Dickinson and Company
  • PerkinElmer, Inc.
  • Bio-Rad Laboratories
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific
  • Siemens Healthcare
  • Abaxis Inc.
  • Roche Diagnostics
  • Abbott Laboratories
  • Danaher Corporation
  • Fluidigm Corporation
  • Micronit BV
  • Illumina Inc.
  • Phalanx Biotech Group Inc.
  • bioMerieux SA
  • Qiagen NV
  • Merck KGaA
  • Cepheid Inc.
  • IDEX Corporation
Product Code: SMRC29793

According to Stratistics MRC, the Global Lab-on-a-chip Market is accounted for $7.3 billion in 2025 and is expected to reach $15.5 billion by 2032 growing at a CAGR of 11.3% during the forecast period. Lab-on-a-chip is a compact analytical device that integrates multiple laboratory processes into a single microfluidic platform. Designed for efficiency, these systems enable rapid biochemical and molecular analysis with minimal sample requirements. By streamlining diagnostic procedures, drug testing, and environmental monitoring, they optimize resource consumption while delivering precise results. Their automated functionality and real-time detection capabilities enhance biomedical research and point-of-care applications.

Market Dynamics:

Driver:

Growing demand for point-of-care (POC) diagnostics

The miniaturized analytical devices offer rapid, precise testing, eliminating the need for extensive laboratory procedures and facilitating immediate medical decisions. With rising prevalence of chronic diseases, clinicians require efficient diagnostic solutions that ensure timely interventions. Lab-on-a-chip systems provide cost-effective, user-friendly alternatives to conventional diagnostic methods, making them indispensable in remote and decentralized healthcare settings.

Restraint:

Complex design and fabrication challenges

Advanced microfluidic systems require precise engineering and specialized materials, increasing development costs. The integration of multiple laboratory functions on a single chip demands high manufacturing accuracy, creating barriers for mass production. Additionally, ensuring compatibility with existing diagnostic workflows presents technical difficulties which hampers the market growth.

Opportunity:

Emerging organ-on-a-chip and human-on-a-chip models

Emerging innovative platforms replicate physiological conditions, allowing researchers to study disease mechanisms and therapeutic responses more efficiently. Lab-on-a-chip devices equipped with microengineered tissues offer predictive insights into drug efficacy, reducing dependency on animal testing. Pharmaceutical companies and research institutions are investing in advanced chip-based models to accelerate clinical trials and personalized medicine initiatives.

Threat:

Competition from traditional lab instruments

Competition from traditional laboratory instruments poses a challenge to lab-on-a-chip adoption in certain sectors. Established diagnostic tools, such as centralized analyzers and automated lab systems, continue to dominate clinical settings due to their high throughput and standardized protocols. Healthcare providers may hesitate to shift towards chip-based platforms, citing concerns about accuracy, regulatory approvals, and integration with existing infrastructure.

Covid-19 Impact:

The pandemic underscored the significance of rapid and decentralized diagnostics, boosting interest in lab-on-a-chip technology. Demand surged for portable testing solutions that could detect infections efficiently, reducing reliance on centralized laboratories. Research efforts accelerated to develop COVID-19 diagnostic chips with high sensitivity and speed, improving disease surveillance capabilities. However, supply chain disruptions affected manufacturing timelines, temporarily slowing market expansion.

The reagents & consumables segment is expected to be the largest during the forecast period

The reagents & consumables segment is expected to account for the largest market share during the forecast period driven by consistent demand for essential chemical components in lab-on-a-chip operations. These materials facilitate sample preparation, biochemical reactions, and analytical processes within microfluidic systems. The expanding use of lab-on-a-chip devices in diagnostic laboratories, pharmaceutical research, and environmental monitoring reinforces steady growth in reagent consumption.

The microfluidics technology segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the microfluidics technology segment is predicted to witness the highest growth rate fueled by advancements in chip-based analytical systems. Microfluidic innovations optimize fluid handling, reaction kinetics, and multiplexed testing, improving diagnostic accuracy and efficiency. The integration of nanotechnology and AI-driven automation further enhances microfluidic capabilities, expanding its role in biomedical applications.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share attributed to strong healthcare infrastructure, extensive research investments, and widespread adoption of advanced diagnostics. The region's emphasis on precision medicine and decentralized testing contributes to the prominence of lab-on-a-chip solutions in clinical and pharmaceutical settings. Regulatory support and ongoing innovation in microfluidics further reinforce North America's leadership in the global market.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR propelled by increasing healthcare access, technological advancements, and growing biomedical research initiatives. Government funding for diagnostics innovation and the rise of personalized medicine are stimulating demand for lab-on-a-chip technology. Expanding biotech industries, particularly in China, Japan, and India, are driving market growth, positioning Asia Pacific as a dynamic hub for next-generation diagnostic development.

Key players in the market

Some of the key players in Lab-on-a-chip Market include Becton, Dickinson and Company, PerkinElmer, Inc., Bio-Rad Laboratories, Agilent Technologies, Inc., Thermo Fisher Scientific, Siemens Healthcare, Abaxis Inc., Roche Diagnostics, Abbott Laboratories, Danaher Corporation, Fluidigm Corporation, Micronit BV, Illumina Inc., Phalanx Biotech Group Inc., bioMerieux SA, Qiagen NV, Merck KGaA, Cepheid Inc., and IDEX Corporation.

Key Developments:

In May 2025, Thermo Fisher Scientific introduced next-generation MS platforms delivering up to 35% faster scan speed and 50% higher multiplexing capacity to accelerate multi-omics and precision medicine research. These tools enhance Thermo Fisher's proteomics portfolio and support breakthroughs in cancer and Alzheimer's studies.

In May 2025, Illumina Inc. Launched DRAGEN v4.4 with enhanced structural variant detection (~30% improvement), new oncology apps, and AWS F2 cloud support. This update improves performance and scalability for clinical and research-grade genomic pipelines.

In May 2025, Danaher Corporation announced a collaboration to develop AI-powered diagnostics and digital tools to enhance clinical insights and patient outcomes. This partnership bridges Danaher's diagnostics reach with AstraZeneca's therapeutic expertise

Products Covered:

  • Reagents & Consumables
  • Instruments
  • Software & Services

Materials Covered:

  • Polymers
  • Glass
  • Silicon
  • Paper
  • Other Materials

Technologies Covered:

  • Microfluidics Technology
  • Optical Technology
  • Electrochemical Technology
  • Microarrays
  • Tissue Biochip / Organ-on-a-chip
  • Other Technologies

Applications Covered:

  • Clinical Diagnostics
  • Drug Discovery & Development
  • Genomics & Proteomics
  • Environmental Monitoring
  • Food Safety & Quality Control
  • Other Applications

End Users Covered:

  • Hospitals & Diagnostic Centers
  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutes
  • Forensic Laboratories
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Lab-on-a-chip Market, By Product

  • 5.1 Introduction
  • 5.2 Reagents & Consumables
    • 5.2.1 Microfluidic Chips/Cartridges
    • 5.2.2 Beads & Particles
    • 5.2.3 Detection Reagents
    • 5.2.4 Buffers & Solutions
  • 5.3 Instruments
    • 5.3.1 Sample Preparation Units
    • 5.3.2 Integrated LOC Systems
    • 5.3.3 Accessories
  • 5.4 Software & Services
    • 5.4.1 Data Analysis Software
    • 5.4.2 Automation & Control Software
    • 5.4.3 Cloud-based Solutions
    • 5.4.4 Custom Chip Design & Fabrication Services
    • 5.4.5 Maintenance & Support Services
    • 5.4.6 Training & Consultation Services

6 Global Lab-on-a-chip Market, By Material

  • 6.1 Introduction
  • 6.2 Polymers
  • 6.3 Glass
  • 6.4 Silicon
  • 6.5 Paper
  • 6.6 Other Materials

7 Global Lab-on-a-chip Market, By Technology

  • 7.1 Introduction
  • 7.2 Microfluidics Technology
  • 7.3 Optical Technology
  • 7.4 Electrochemical Technology
  • 7.5 Microarrays
  • 7.6 Tissue Biochip / Organ-on-a-chip
  • 7.7 Other Technologies

8 Global Lab-on-a-chip Market, By Application

  • 8.1 Introduction
  • 8.2 Clinical Diagnostics
  • 8.3 Drug Discovery & Development
  • 8.4 Genomics & Proteomics
  • 8.5 Environmental Monitoring
  • 8.6 Food Safety & Quality Control
  • 8.7 Other Applications

9 Global Lab-on-a-chip Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Diagnostic Centers
  • 9.3 Biotechnology & Pharmaceutical Companies
  • 9.4 Academic & Research Institutes
  • 9.5 Forensic Laboratories
  • 9.6 Other End Users

10 Global Lab-on-a-chip Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Becton, Dickinson and Company
  • 12.2 PerkinElmer, Inc.
  • 12.3 Bio-Rad Laboratories
  • 12.4 Agilent Technologies, Inc.
  • 12.5 Thermo Fisher Scientific
  • 12.6 Siemens Healthcare
  • 12.7 Abaxis Inc.
  • 12.8 Roche Diagnostics
  • 12.9 Abbott Laboratories
  • 12.10 Danaher Corporation
  • 12.11 Fluidigm Corporation
  • 12.12 Micronit BV
  • 12.13 Illumina Inc.
  • 12.14 Phalanx Biotech Group Inc.
  • 12.15 bioMerieux SA
  • 12.16 Qiagen NV
  • 12.17 Merck KGaA
  • 12.18 Cepheid Inc.
  • 12.19 IDEX Corporation

List of Tables

  • Table 1 Global Lab-on-a-chip Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Lab-on-a-chip Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Lab-on-a-chip Market Outlook, By Reagents & Consumables (2024-2032) ($MN)
  • Table 4 Global Lab-on-a-chip Market Outlook, By Microfluidic Chips/Cartridges (2024-2032) ($MN)
  • Table 5 Global Lab-on-a-chip Market Outlook, By Beads & Particles (2024-2032) ($MN)
  • Table 6 Global Lab-on-a-chip Market Outlook, By Detection Reagents (2024-2032) ($MN)
  • Table 7 Global Lab-on-a-chip Market Outlook, By Buffers & Solutions (2024-2032) ($MN)
  • Table 8 Global Lab-on-a-chip Market Outlook, By Instruments (2024-2032) ($MN)
  • Table 9 Global Lab-on-a-chip Market Outlook, By Sample Preparation Units (2024-2032) ($MN)
  • Table 10 Global Lab-on-a-chip Market Outlook, By Integrated LOC Systems (2024-2032) ($MN)
  • Table 11 Global Lab-on-a-chip Market Outlook, By Accessories (2024-2032) ($MN)
  • Table 12 Global Lab-on-a-chip Market Outlook, By Software & Services (2024-2032) ($MN)
  • Table 13 Global Lab-on-a-chip Market Outlook, By Data Analysis Software (2024-2032) ($MN)
  • Table 14 Global Lab-on-a-chip Market Outlook, By Automation & Control Software (2024-2032) ($MN)
  • Table 15 Global Lab-on-a-chip Market Outlook, By Cloud-based Solutions (2024-2032) ($MN)
  • Table 16 Global Lab-on-a-chip Market Outlook, By Custom Chip Design & Fabrication Services (2024-2032) ($MN)
  • Table 17 Global Lab-on-a-chip Market Outlook, By Maintenance & Support Services (2024-2032) ($MN)
  • Table 18 Global Lab-on-a-chip Market Outlook, By Training & Consultation Services (2024-2032) ($MN)
  • Table 19 Global Lab-on-a-chip Market Outlook, By Material (2024-2032) ($MN)
  • Table 20 Global Lab-on-a-chip Market Outlook, By Polymers (2024-2032) ($MN)
  • Table 21 Global Lab-on-a-chip Market Outlook, By Glass (2024-2032) ($MN)
  • Table 22 Global Lab-on-a-chip Market Outlook, By Silicon (2024-2032) ($MN)
  • Table 23 Global Lab-on-a-chip Market Outlook, By Paper (2024-2032) ($MN)
  • Table 24 Global Lab-on-a-chip Market Outlook, By Other Materials (2024-2032) ($MN)
  • Table 25 Global Lab-on-a-chip Market Outlook, By Technology (2024-2032) ($MN)
  • Table 26 Global Lab-on-a-chip Market Outlook, By Microfluidics Technology (2024-2032) ($MN)
  • Table 27 Global Lab-on-a-chip Market Outlook, By Optical Technology (2024-2032) ($MN)
  • Table 28 Global Lab-on-a-chip Market Outlook, By Electrochemical Technology (2024-2032) ($MN)
  • Table 29 Global Lab-on-a-chip Market Outlook, By Microarrays (2024-2032) ($MN)
  • Table 30 Global Lab-on-a-chip Market Outlook, By Tissue Biochip / Organ-on-a-chip (2024-2032) ($MN)
  • Table 31 Global Lab-on-a-chip Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 32 Global Lab-on-a-chip Market Outlook, By Application (2024-2032) ($MN)
  • Table 33 Global Lab-on-a-chip Market Outlook, By Clinical Diagnostics (2024-2032) ($MN)
  • Table 34 Global Lab-on-a-chip Market Outlook, By Drug Discovery & Development (2024-2032) ($MN)
  • Table 35 Global Lab-on-a-chip Market Outlook, By Genomics & Proteomics (2024-2032) ($MN)
  • Table 36 Global Lab-on-a-chip Market Outlook, By Environmental Monitoring (2024-2032) ($MN)
  • Table 37 Global Lab-on-a-chip Market Outlook, By Food Safety & Quality Control (2024-2032) ($MN)
  • Table 38 Global Lab-on-a-chip Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 39 Global Lab-on-a-chip Market Outlook, By End User (2024-2032) ($MN)
  • Table 40 Global Lab-on-a-chip Market Outlook, By Hospitals & Diagnostic Centers (2024-2032) ($MN)
  • Table 41 Global Lab-on-a-chip Market Outlook, By Biotechnology & Pharmaceutical Companies (2024-2032) ($MN)
  • Table 42 Global Lab-on-a-chip Market Outlook, By Academic & Research Institutes (2024-2032) ($MN)
  • Table 43 Global Lab-on-a-chip Market Outlook, By Forensic Laboratories (2024-2032) ($MN)
  • Table 44 Global Lab-on-a-chip Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.